MIP PHARMA DANMARK ApS: Financial statements 2020
CVR: 32886280
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -24,001 and a net result of DKK -37,935 compared with DKK -33,370 the year before. Equity in the 2020 report amounted to DKK -255,104.
- Gross Profit
- DKK -24,001
- Profit/Loss
- DKK -37,935
- Equity
- DKK -255,104
- Total Assets
- DKK 15,928
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -24 t. | -38 t. | -255 t. | 0 |
| 2019 | - | -23 t. | -33 t. | -217 t. | 0 |
| 2018 | - | -27 t. | -35 t. | -184 t. | 0 |
| 2017 | - | -34 t. | -39 t. | -149 t. | - |
| 2016 | - | -34 t. | -43 t. | -109 t. | - |
Official annual report
How creditworthy is MIP PHARMA DANMARK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of November 10, 2020, Martin Osterhues is registered as director of MIP PHARMA DANMARK ApS.
As of November 10, 2020, Ursula Seidel has stepped down as director of MIP PHARMA DANMARK ApS.
About MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.